CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 盐酸齐拉西酮Ziprasidone Hydrochloride
Ziprasidone Hydrochloride

盐酸齐拉西酮 杂质对照品Ziprasidone Hydrochloride Impurities

EP34 个杂质条目34 impurity entries

本页汇总 盐酸齐拉西酮 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Ziprasidone Hydrochloride with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 盐酸齐拉西酮(Ziprasidone Hydrochloride)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesIdentification of Novel Impurity of Ziprasidone
    Journal of pharmaceutical and biomedical analysis · 2022 · Murkute SR et al.  ·  PMID 34678557  ·  DOI
  2. 杂质研究Impurity studiesDevelopment of rapid and robust stability-indicating method for analysis of ziprasidone (hydrochloride and freebase) as drug substance and in medicines by UPLC
    Acta poloniae pharmaceutica · 2012 · Zakowiecki D, Cal K  ·  PMID 23061276
  3. 杂质研究Impurity studiesStability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules
    Journal of fluorescence · 2011 · Walash MI et al.  ·  PMID 21327537  ·  DOI
  4. 杂质研究Impurity studiesFormulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect
    Pharmaceutical development and technology · 2016 · Banerjee S et al.  ·  PMID 26135230  ·  DOI

盐酸齐拉西酮 —— 原料药与杂质对照品Ziprasidone Hydrochloride — drug substance & impurities

共 34 个条目(含原料药本体)34 items incl. the drug substance
Ziprasidone Hydrochloride structure
EP原料药 APIAPI
盐酸齐拉西酮Ziprasidone Hydrochloride
Ziprasidone Hydrochloride
CAS No.122883-93-6
Chemical FormulaC21H21ClN4OS·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 6 (Ziprasidone Hydrochloride Monohydrate EP Impurity A) structure
EPA
盐酸齐拉西酮杂质6 (盐酸齐拉西酮一水合物EP杂质A)Ziprasidone Hydrochloride Impurity 6 (Ziprasidone Hydrochloride Monohydrate EP Impurity A)
Ziprasidone Hydrochloride Impurity 6 (Ziprasidone Hydrochloride Monohydrate EP Impurity A)
CAS No.87691-87-0
Chemical FormulaC11H13N3S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 6 Hydrochloride (Ziprasidone Hydrochloride Monohydrate EP Impurity A Hydrochloride) structure
EPA
盐酸齐拉西酮杂质6 盐酸盐 (盐酸齐拉西酮一水合物EP杂质A 盐酸盐)Ziprasidone Hydrochloride Impurity 6 Hydrochloride (Ziprasidone Hydrochloride Monohydrate EP Impurity A Hydrochloride)
Ziprasidone Hydrochloride Impurity 6 Hydrochloride (Ziprasidone Hydrochloride Monohydrate EP Impurity A Hydrochloride)
CAS No.87691-88-1
Chemical FormulaC11H13N3S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 2 (Ziprasidone Hydrochloride Monohydrate EP Impurity B) structure
EPB
盐酸齐拉西酮杂质2 (盐酸齐拉西酮一水合物EP杂质B)Ziprasidone Hydrochloride Impurity 2 (Ziprasidone Hydrochloride Monohydrate EP Impurity B)
Ziprasidone Hydrochloride Impurity 2 (Ziprasidone Hydrochloride Monohydrate EP Impurity B)
CAS No.1159977-56-6
Chemical FormulaC21H19ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 3 (Ziprasidone Hydrochloride Monohydrate EP Impurity C) structure
EPC
盐酸齐拉西酮杂质3 (盐酸齐拉西酮一水合物EP杂质C)Ziprasidone Hydrochloride Impurity 3 (Ziprasidone Hydrochloride Monohydrate EP Impurity C)
Ziprasidone Hydrochloride Impurity 3 (Ziprasidone Hydrochloride Monohydrate EP Impurity C)
CAS No.1159977-64-6
Chemical FormulaC21H23ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 3 Sodium Salt (Ziprasidone Hydrochloride Monohydrate EP Impurity C Sodium Salt) structure
EPC
盐酸齐拉西酮杂质3 钠盐 (盐酸齐拉西酮一水合物EP杂质C 钠盐)Ziprasidone Hydrochloride Impurity 3 Sodium Salt (Ziprasidone Hydrochloride Monohydrate EP Impurity C Sodium Salt)
Ziprasidone Hydrochloride Impurity 3 Sodium Salt (Ziprasidone Hydrochloride Monohydrate EP Impurity C Sodium Salt)
CAS No.1798033-44-9
Chemical FormulaC21H22ClN4O2S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 4 CRS (Ziprasidone Hydrochloride Monohydrate EP Impurity D CRS) structure
EPD
盐酸齐拉西酮杂质4 CRS (盐酸齐拉西酮一水合物EP杂质D CRS)Ziprasidone Hydrochloride Impurity 4 CRS (Ziprasidone Hydrochloride Monohydrate EP Impurity D CRS)
Ziprasidone Hydrochloride Impurity 4 CRS (Ziprasidone Hydrochloride Monohydrate EP Impurity D CRS)
CAS No.1303996-68-0
Chemical FormulaC42H40Cl2N8O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 5 (Ziprasidone Hydrochloride Monohydrate EP Impurity E) structure
EPE
盐酸齐拉西酮杂质5 (盐酸齐拉西酮一水合物EP杂质E)Ziprasidone Hydrochloride Impurity 5 (Ziprasidone Hydrochloride Monohydrate EP Impurity E)
Ziprasidone Hydrochloride Impurity 5 (Ziprasidone Hydrochloride Monohydrate EP Impurity E)
CAS No.1159977-04-4
Chemical FormulaC28H24ClN5OS2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone-d8 structure
—
齐拉西酮-d8Ziprasidone-d8
Ziprasidone-d8
CAS No.1126745-58-1
Chemical FormulaC21H13D8ClN4OS
Purity>95%询价On request
Ziprasidone Hydrochloride Monohydrate structure
—
盐酸齐拉西酮一水合物Ziprasidone Hydrochloride Monohydrate
Ziprasidone Hydrochloride Monohydrate
CAS No.138982-67-9
Chemical FormulaC21H21ClN4OS·HCl·H2O
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone structure
—
齐拉西酮Ziprasidone
Ziprasidone
CAS No.146939-27-7
Chemical FormulaC21H21ClN4OS
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Mesylate structure
—
甲磺酸齐拉西酮Ziprasidone Mesylate
Ziprasidone Mesylate
CAS No.185021-64-1
Chemical Formula21H21ClN4OS·CH4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 1 (Ziprasidone N-Oxide) structure
1
盐酸齐拉西酮杂质1 (齐拉西酮氮氧化物)Ziprasidone Hydrochloride Impurity 1 (Ziprasidone N-Oxide)
Ziprasidone Hydrochloride Impurity 1 (Ziprasidone N-Oxide)
CAS No.188797-76-4
Chemical FormulaC21H21ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 7 structure
7
盐酸齐拉西酮杂质7Ziprasidone Hydrochloride Impurity 7
Ziprasidone Hydrochloride Impurity 7
CAS No.884305-08-2
Chemical FormulaC21H21ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 9 structure
9
盐酸齐拉西酮杂质9Ziprasidone Hydrochloride Impurity 9
Ziprasidone Hydrochloride Impurity 9
CAS No.194280-91-6
Chemical FormulaC22H25ClN4OS
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 10 structure
10
盐酸齐拉西酮杂质10Ziprasidone Hydrochloride Impurity 10
Ziprasidone Hydrochloride Impurity 10
CAS No.118307-04-3
Chemical FormulaC10H7Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 11 structure
11
盐酸齐拉西酮杂质11Ziprasidone Hydrochloride Impurity 11
Ziprasidone Hydrochloride Impurity 11
CAS No.884305-06-0
Chemical FormulaC10H9Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 12 structure
12
盐酸齐拉西酮杂质12Ziprasidone Hydrochloride Impurity 12
Ziprasidone Hydrochloride Impurity 12
CAS No.188797-80-0
Chemical FormulaC21H21ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 13 structure
13
盐酸齐拉西酮杂质13Ziprasidone Hydrochloride Impurity 13
Ziprasidone Hydrochloride Impurity 13
CAS No.118289-55-7
Chemical FormulaC10H9Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 14 structure
14
盐酸齐拉西酮杂质14Ziprasidone Hydrochloride Impurity 14
Ziprasidone Hydrochloride Impurity 14
CAS No.118305-72-9
Chemical FormulaC21H22N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 15 structure
15
盐酸齐拉西酮杂质15Ziprasidone Hydrochloride Impurity 15
Ziprasidone Hydrochloride Impurity 15
CAS No.2385310-50-7
Chemical FormulaC10H9Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 19 structure
19
盐酸齐拉西酮杂质19Ziprasidone Hydrochloride Impurity 19
Ziprasidone Hydrochloride Impurity 19
CAS No.1246820-87-0
Chemical FormulaC21H21ClN4O3S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 19 Monomer structure
19
盐酸齐拉西酮杂质19 单体Ziprasidone Hydrochloride Impurity 19 Monomer
Ziprasidone Hydrochloride Impurity 19 Monomer
CAS No.188797-77-5
Chemical FormulaC21H21ClN4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 21 structure
21
盐酸齐拉西酮杂质21Ziprasidone Hydrochloride Impurity 21
Ziprasidone Hydrochloride Impurity 21
CAS No.510703-85-2
Chemical FormulaC10H10ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 22 structure
22
盐酸齐拉西酮杂质22Ziprasidone Hydrochloride Impurity 22
Ziprasidone Hydrochloride Impurity 22
CAS No.774595-88-9
Chemical FormulaC22H23ClN4OS
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 23 structure
23
盐酸齐拉西酮杂质23Ziprasidone Hydrochloride Impurity 23
Ziprasidone Hydrochloride Impurity 23
CAS No.884305-07-1
Chemical FormulaC21H19ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 24 structure
24
盐酸齐拉西酮杂质24Ziprasidone Hydrochloride Impurity 24
Ziprasidone Hydrochloride Impurity 24
CAS No.195244-32-7
Chemical FormulaC21H23ClN4OS
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 33 structure
33
盐酸齐拉西酮杂质33Ziprasidone Hydrochloride Impurity 33
Ziprasidone Hydrochloride Impurity 33
CAS No.147124-32-1
Chemical FormulaC11H10ClNO6
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 34 structure
34
盐酸齐拉西酮杂质34Ziprasidone Hydrochloride Impurity 34
Ziprasidone Hydrochloride Impurity 34
CAS No.177985-31-8
Chemical FormulaC8H8ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 47 structure
47
盐酸齐拉西酮杂质47Ziprasidone Hydrochloride Impurity 47
Ziprasidone Hydrochloride Impurity 47
CAS No.188797-79-7
Chemical FormulaC14H18ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 48 structure
48
盐酸齐拉西酮杂质48Ziprasidone Hydrochloride Impurity 48
Ziprasidone Hydrochloride Impurity 48
CAS No.1311090-44-4
Chemical FormulaC42H38Cl2N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 52 structure
52
盐酸齐拉西酮杂质52Ziprasidone Hydrochloride Impurity 52
Ziprasidone Hydrochloride Impurity 52
CAS No.1303996-69-1
Chemical FormulaC21H19ClN4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 56 structure
56
盐酸齐拉西酮杂质56Ziprasidone Hydrochloride Impurity 56
Ziprasidone Hydrochloride Impurity 56
CAS No.25369-33-9
Chemical FormulaC8H6ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Ziprasidone Hydrochloride Impurity 57 structure
57
盐酸齐拉西酮杂质57Ziprasidone Hydrochloride Impurity 57
Ziprasidone Hydrochloride Impurity 57
CAS No.20870-77-3
Chemical FormulaC8H6ClNO
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

盐酸齐拉西酮 —— 研究文献与合成路线Ziprasidone Hydrochloride — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 盐酸齐拉西酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ziprasidone Hydrochloride. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. PREPARATION OF ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE
    MANDAVA BRAHMESWARA RAO VENKATA NAGA, DEVARAKONDA SURYA NARAYANA, PEDDIREDDY SUBBA REDDY, SINGAMSETTY RADHA KRISHNA, et al. · 公开号 WO2009032558WO2009032558 · 2009
  2. PREPARATION OF ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE
    MANDAVA BRAHMESWARA RAO VENKATA NAGA, DEVARAKONDA SURYA NARAYANA, PEDDIREDDY SUBBA REDDY, SINGAMSETTY RADHA KRISHNA, et al. · 公开号 EP2197446EP2197446 · 2010
  3. ZIPRASIDONE HYDROCHLORIDE POLYMORPH AND PROCESS FOR ITS PREPARATION
    VENTIMIGLIA GIANPIERO, ALLEGRINI PIETRO, CASTALDI GRAZIANO · 公开号 WO2005108395WO2005108395 · 2005
  4. Ziprasidone Hydrochloride Polymorph and Process for Its Preparation
    VENTIMIGLIA GIANPIERO, ALLEGRINI PIETRO, CASTALDI GRAZIANO · 公开号 US2007225295US2007225295 · 2007
  5. ZIPRASIDONE HYDROCHLORIDE POLYMORPH AND PROCESS FOR ITS PREPARATION
    VENTIMIGLIA Gianpiero, ALLEGRINI Pietro, CASTALDI Graziano · 公开号 EP1751148EP1751148 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

盐酸齐拉西酮 杂质谱研究要点Ziprasidone Hydrochloride — impurity profiling notes

下面这些是拿到 盐酸齐拉西酮 的 34 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 34 impurity entries for Ziprasidone Hydrochloride, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances